Clinical trial
A Phase II Study of Docetaxel and S-1 as First-line Chemotherapy in Patients With Advanced Esophageal Cancer
NCT01693432 is registered in ClinicalTrials.gov with Hallym University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Docetaxel and S-1 as First-line Chemotherapy in Patients With Advanced Esophageal Cancer
- Lead sponsor
- Hallym University Medical Center
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- November 30, 2011
- Completion date
- June 30, 2018
- Enrollment
- 37 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.